

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.70751053 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 4.70751053 |
| 3 | aromatic amino acid family catabolic process (GO:0009074) | 4.53822781 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.53232340 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.53232340 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 4.52368349 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 4.52368349 |
| 8 | tryptophan catabolic process (GO:0006569) | 4.52368349 |
| 9 | tryptophan metabolic process (GO:0006568) | 4.27015447 |
| 10 | kynurenine metabolic process (GO:0070189) | 4.22321924 |
| 11 | glyoxylate metabolic process (GO:0046487) | 4.12142348 |
| 12 | glycine metabolic process (GO:0006544) | 4.08069393 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.02554548 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 4.01424577 |
| 15 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.99978067 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.97048654 |
| 17 | cysteine metabolic process (GO:0006534) | 3.85174495 |
| 18 | serine family amino acid catabolic process (GO:0009071) | 3.84129636 |
| 19 | urea metabolic process (GO:0019627) | 3.82613090 |
| 20 | urea cycle (GO:0000050) | 3.82613090 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.82298700 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.80131260 |
| 23 | response to peptidoglycan (GO:0032494) | 3.79483607 |
| 24 | serine family amino acid biosynthetic process (GO:0009070) | 3.78372093 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.74032627 |
| 26 | homocysteine metabolic process (GO:0050667) | 3.68285442 |
| 27 | serine family amino acid metabolic process (GO:0009069) | 3.64214655 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.60396149 |
| 29 | bile acid biosynthetic process (GO:0006699) | 3.56988388 |
| 30 | negative regulation of cell killing (GO:0031342) | 3.53469132 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.53469132 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 3.52489294 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 3.52404838 |
| 34 | negative regulation of phagocytosis (GO:0050765) | 3.51484904 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.48563794 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 3.47474928 |
| 37 | DNA deamination (GO:0045006) | 3.46201925 |
| 38 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.43062537 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 3.40063168 |
| 40 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.39439778 |
| 41 | amino-acid betaine metabolic process (GO:0006577) | 3.36819690 |
| 42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.34415099 |
| 43 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.33946104 |
| 44 | positive regulation of histone deacetylation (GO:0031065) | 3.33850870 |
| 45 | imidazole-containing compound metabolic process (GO:0052803) | 3.33778348 |
| 46 | NIK/NF-kappaB signaling (GO:0038061) | 3.31902447 |
| 47 | proline metabolic process (GO:0006560) | 3.28956730 |
| 48 | complement activation, alternative pathway (GO:0006957) | 3.28408214 |
| 49 | neutrophil activation involved in immune response (GO:0002283) | 3.27731710 |
| 50 | cellular biogenic amine catabolic process (GO:0042402) | 3.27073121 |
| 51 | amine catabolic process (GO:0009310) | 3.27073121 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 3.26906770 |
| 53 | negative regulation of fibrinolysis (GO:0051918) | 3.23621354 |
| 54 | lysine metabolic process (GO:0006553) | 3.22551440 |
| 55 | lysine catabolic process (GO:0006554) | 3.22551440 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 3.22355363 |
| 57 | negative regulation of sterol transport (GO:0032372) | 3.22355363 |
| 58 | protein carboxylation (GO:0018214) | 3.21841423 |
| 59 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.21841423 |
| 60 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.21710419 |
| 61 | mannose metabolic process (GO:0006013) | 3.19954214 |
| 62 | regulation of mast cell degranulation (GO:0043304) | 3.19290163 |
| 63 | NAD biosynthetic process (GO:0009435) | 3.18360488 |
| 64 | regulation of protein activation cascade (GO:2000257) | 3.18008040 |
| 65 | L-serine metabolic process (GO:0006563) | 3.17999432 |
| 66 | bile acid metabolic process (GO:0008206) | 3.16773224 |
| 67 | regulation of cholesterol esterification (GO:0010872) | 3.16414595 |
| 68 | proline biosynthetic process (GO:0006561) | 3.16267689 |
| 69 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.13750285 |
| 70 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.13750285 |
| 71 | modulation by symbiont of host immune response (GO:0052553) | 3.13750285 |
| 72 | positive regulation by symbiont of host defense response (GO:0052509) | 3.13750285 |
| 73 | modulation by symbiont of host defense response (GO:0052031) | 3.13750285 |
| 74 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.13750285 |
| 75 | detection of bacterium (GO:0016045) | 3.12961412 |
| 76 | indolalkylamine metabolic process (GO:0006586) | 3.12793076 |
| 77 | phospholipid efflux (GO:0033700) | 3.12759019 |
| 78 | alpha-amino acid catabolic process (GO:1901606) | 3.11035069 |
| 79 | positive thymic T cell selection (GO:0045059) | 3.10096271 |
| 80 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.09758995 |
| 81 | regulation of gamma-delta T cell activation (GO:0046643) | 3.09702199 |
| 82 | alpha-linolenic acid metabolic process (GO:0036109) | 3.08572789 |
| 83 | regulation of fibrinolysis (GO:0051917) | 3.08020803 |
| 84 | triglyceride homeostasis (GO:0070328) | 3.06087402 |
| 85 | acylglycerol homeostasis (GO:0055090) | 3.06087402 |
| 86 | B cell mediated immunity (GO:0019724) | 3.05900170 |
| 87 | cellular glucuronidation (GO:0052695) | 3.02963288 |
| 88 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.02149097 |
| 89 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.02149097 |
| 90 | positive regulation of protein deacetylation (GO:0090312) | 3.01130655 |
| 91 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.00682419 |
| 92 | reverse cholesterol transport (GO:0043691) | 3.00352576 |
| 93 | plasma lipoprotein particle assembly (GO:0034377) | 2.99750687 |
| 94 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.99550616 |
| 95 | bile acid and bile salt transport (GO:0015721) | 2.99386093 |
| 96 | protein-lipid complex remodeling (GO:0034368) | 2.98748145 |
| 97 | macromolecular complex remodeling (GO:0034367) | 2.98748145 |
| 98 | plasma lipoprotein particle remodeling (GO:0034369) | 2.98748145 |
| 99 | tetrahydrofolate metabolic process (GO:0046653) | 2.98384128 |
| 100 | negative regulation of interleukin-12 production (GO:0032695) | 2.97275445 |
| 101 | regulation of complement activation (GO:0030449) | 2.96919613 |
| 102 | pentose metabolic process (GO:0019321) | 2.94435520 |
| 103 | T cell apoptotic process (GO:0070231) | 2.94327002 |
| 104 | positive regulation of antigen processing and presentation (GO:0002579) | 2.94158104 |
| 105 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.92635298 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.92635298 |
| 107 | regulation of B cell apoptotic process (GO:0002902) | 2.92325477 |
| 108 | ethanol oxidation (GO:0006069) | 2.91821083 |
| 109 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.90266145 |
| 110 | detection of other organism (GO:0098543) | 2.88532949 |
| 111 | aldehyde catabolic process (GO:0046185) | 2.88093382 |
| 112 | cellular amino acid catabolic process (GO:0009063) | 2.87211658 |
| 113 | response to nitrosative stress (GO:0051409) | 2.86878405 |
| 114 | intestinal cholesterol absorption (GO:0030299) | 2.85370765 |
| 115 | blood coagulation, intrinsic pathway (GO:0007597) | 2.84665641 |
| 116 | defense response to protozoan (GO:0042832) | 2.83579536 |
| 117 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.82503889 |
| 118 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.82360124 |
| 119 | regulation of B cell differentiation (GO:0045577) | 2.78923286 |
| 120 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.78673791 |
| 121 | regulation of antigen processing and presentation (GO:0002577) | 2.78538698 |
| 122 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.78300565 |
| 123 | response to protozoan (GO:0001562) | 2.78197438 |
| 124 | benzene-containing compound metabolic process (GO:0042537) | 2.77748117 |
| 125 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.77102841 |
| 126 | thymic T cell selection (GO:0045061) | 2.76750835 |
| 127 | plasma lipoprotein particle clearance (GO:0034381) | 2.76288187 |
| 128 | amyloid precursor protein catabolic process (GO:0042987) | 2.76055321 |
| 129 | regulation of T cell tolerance induction (GO:0002664) | 2.74509019 |
| 130 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.74296604 |
| 131 | one-carbon metabolic process (GO:0006730) | 2.73876768 |
| 132 | B cell receptor signaling pathway (GO:0050853) | 2.73686548 |
| 133 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.72454940 |
| 134 | tyrosine metabolic process (GO:0006570) | 2.72409271 |
| 135 | urate metabolic process (GO:0046415) | 2.72125899 |
| 136 | ribosomal small subunit assembly (GO:0000028) | 2.72114872 |
| 137 | cholesterol efflux (GO:0033344) | 2.71933633 |
| 138 | positive regulation of mast cell degranulation (GO:0043306) | 2.71425251 |
| 139 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.71425251 |
| 140 | positive regulation of interferon-alpha production (GO:0032727) | 2.71384703 |
| 141 | regulation of mast cell activation (GO:0033003) | 2.70415422 |
| 142 | cellular modified amino acid catabolic process (GO:0042219) | 2.70165949 |
| 143 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.70033044 |
| 144 | macrophage activation involved in immune response (GO:0002281) | 2.69850378 |
| 145 | response to type I interferon (GO:0034340) | 2.69202349 |
| 146 | cholesterol homeostasis (GO:0042632) | 2.69149525 |
| 147 | drug catabolic process (GO:0042737) | 2.68643294 |
| 148 | folic acid metabolic process (GO:0046655) | 2.68362567 |
| 149 | response to interferon-beta (GO:0035456) | 2.67491189 |
| 150 | carnitine metabolic process (GO:0009437) | 2.67244913 |
| 151 | uronic acid metabolic process (GO:0006063) | 2.66251273 |
| 152 | glucuronate metabolic process (GO:0019585) | 2.66251273 |
| 153 | leukocyte aggregation (GO:0070486) | 2.65635627 |
| 154 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.65133495 |
| 155 | regulation of interferon-alpha production (GO:0032647) | 2.65065561 |
| 156 | negative regulation of innate immune response (GO:0045824) | 2.64951127 |
| 157 | regulation of leukocyte degranulation (GO:0043300) | 2.64857996 |
| 158 | type I interferon signaling pathway (GO:0060337) | 2.63652449 |
| 159 | cellular response to type I interferon (GO:0071357) | 2.63652449 |
| 160 | valine metabolic process (GO:0006573) | 2.63418927 |
| 161 | sterol homeostasis (GO:0055092) | 2.61959722 |
| 162 | T cell selection (GO:0045058) | 2.61825624 |
| 163 | primary alcohol catabolic process (GO:0034310) | 2.61671087 |
| 164 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.61636667 |
| 165 | positive regulation of mast cell activation (GO:0033005) | 2.61620573 |
| 166 | protein-lipid complex assembly (GO:0065005) | 2.61430953 |
| 167 | lymphocyte apoptotic process (GO:0070227) | 2.60638318 |
| 168 | leukocyte apoptotic process (GO:0071887) | 2.59245268 |
| 169 | response to muramyl dipeptide (GO:0032495) | 2.59236141 |
| 170 | organic acid catabolic process (GO:0016054) | 2.58337096 |
| 171 | carboxylic acid catabolic process (GO:0046395) | 2.58337096 |
| 172 | negative thymic T cell selection (GO:0045060) | 2.55376805 |
| 173 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.54778674 |
| 174 | tolerance induction (GO:0002507) | 2.54224580 |
| 175 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.52123377 |
| 176 | programmed necrotic cell death (GO:0097300) | 2.51287874 |
| 177 | autophagic vacuole fusion (GO:0000046) | 2.48070341 |
| 178 | Peyers patch development (GO:0048541) | 2.47715755 |
| 179 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.47715755 |
| 180 | amino sugar catabolic process (GO:0046348) | 2.46312569 |
| 181 | cellular response to interferon-beta (GO:0035458) | 2.45250647 |
| 182 | regulation of defense response to virus by host (GO:0050691) | 2.43821400 |
| 183 | cellular response to virus (GO:0098586) | 2.42727911 |
| 184 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.42683948 |
| 185 | cellular response to exogenous dsRNA (GO:0071360) | 2.41940369 |
| 186 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.41727189 |
| 187 | positive regulation of T cell apoptotic process (GO:0070234) | 2.41563476 |
| 188 | regulation of tolerance induction (GO:0002643) | 2.40158654 |
| 189 | negative T cell selection (GO:0043383) | 2.39825317 |
| 190 | myeloid cell activation involved in immune response (GO:0002275) | 2.39823834 |
| 191 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.38881910 |
| 192 | positive regulation of defense response to virus by host (GO:0002230) | 2.38331900 |
| 193 | respiratory burst (GO:0045730) | 2.38006161 |
| 194 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.36781031 |
| 195 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.35988810 |
| 196 | negative regulation of B cell apoptotic process (GO:0002903) | 2.35364561 |
| 197 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.34837943 |
| 198 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.33573508 |
| 199 | negative regulation of interleukin-6 production (GO:0032715) | 2.32326664 |
| 200 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.30570096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.52655599 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.37002416 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.85989031 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.59983391 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.52719563 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.12408071 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.73322703 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.68504774 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.66577952 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.60005981 |
| 11 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.54803205 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.30906967 |
| 13 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.20721869 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.14549394 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.04504829 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.00523851 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.00045735 |
| 18 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.95662668 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.91379770 |
| 20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.89159812 |
| 21 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.86923976 |
| 22 | P68_20966046_ChIP-Seq_HELA_Human | 1.80138909 |
| 23 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.76570373 |
| 24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.74584863 |
| 25 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.74395218 |
| 26 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.74344523 |
| 27 | MAF_26560356_Chip-Seq_TH2_Human | 1.74060911 |
| 28 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.71952893 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70103885 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63580986 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63071180 |
| 32 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.62391121 |
| 33 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.62379737 |
| 34 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.58963331 |
| 35 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.58291254 |
| 36 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.50742435 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.49085811 |
| 38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.48743263 |
| 39 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.47013846 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46036118 |
| 41 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45403745 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.43997486 |
| 43 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43761396 |
| 44 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.43233648 |
| 45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.42646173 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42312355 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.40852719 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.40364480 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38951813 |
| 50 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.38371463 |
| 51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.38137640 |
| 52 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36619460 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.36401777 |
| 54 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36083225 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35969633 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.35739235 |
| 57 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.34310666 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33393655 |
| 59 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.33241896 |
| 60 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32989740 |
| 61 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.31807497 |
| 62 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.31758353 |
| 63 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.31329316 |
| 64 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.30626753 |
| 65 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30517099 |
| 66 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.29712650 |
| 67 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.29142870 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28916893 |
| 69 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.28867066 |
| 70 | MYB_26560356_Chip-Seq_TH2_Human | 1.28534089 |
| 71 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28032697 |
| 72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26234352 |
| 73 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.26073556 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26038503 |
| 75 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.24466167 |
| 76 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.23510192 |
| 77 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22606825 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22471870 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22001993 |
| 80 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21686628 |
| 81 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.21285790 |
| 82 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.20908673 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20720695 |
| 84 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.20252360 |
| 85 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.19794600 |
| 86 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.19760227 |
| 87 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.19475897 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.18464735 |
| 89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18175698 |
| 90 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.16815497 |
| 91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16282116 |
| 92 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15198233 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15124579 |
| 94 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.14876777 |
| 95 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.14544473 |
| 96 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.13773755 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13214045 |
| 98 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13163772 |
| 99 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.13138732 |
| 100 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12587412 |
| 101 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12341790 |
| 102 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.11212175 |
| 103 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.11147656 |
| 104 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11067484 |
| 105 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.10687180 |
| 106 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10545916 |
| 107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10527627 |
| 108 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.10420341 |
| 109 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10398134 |
| 110 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.09891492 |
| 111 | P300_27268052_Chip-Seq_Bcells_Human | 1.09538252 |
| 112 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09176766 |
| 113 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.07776581 |
| 114 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.07719727 |
| 115 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07312641 |
| 116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06992286 |
| 117 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06534510 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06514600 |
| 119 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.05858578 |
| 120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05725839 |
| 121 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05596244 |
| 122 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05535038 |
| 123 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05193066 |
| 124 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04810581 |
| 125 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.04794338 |
| 126 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04503467 |
| 127 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04060124 |
| 128 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.01973796 |
| 129 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.99934828 |
| 130 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99255393 |
| 131 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99172759 |
| 132 | MAF_26560356_Chip-Seq_TH1_Human | 0.98830174 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98280429 |
| 134 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97878633 |
| 135 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.95923894 |
| 136 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.95721074 |
| 137 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95701298 |
| 138 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.92828335 |
| 139 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.92612332 |
| 140 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92416737 |
| 141 | MYB_26560356_Chip-Seq_TH1_Human | 0.92243987 |
| 142 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.92140141 |
| 143 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91820208 |
| 144 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90961526 |
| 145 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89111281 |
| 146 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.89099150 |
| 147 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.88466433 |
| 148 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.86688151 |
| 149 | UTX_26944678_Chip-Seq_JUKART_Human | 0.86441856 |
| 150 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.85009445 |
| 151 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.83963491 |
| 152 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.83439233 |
| 153 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.83292416 |
| 154 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83021437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.38390081 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.16874777 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.24295582 |
| 4 | MP0005365_abnormal_bile_salt | 3.96590269 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.48086603 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.23918912 |
| 7 | MP0009840_abnormal_foam_cell | 2.88136803 |
| 8 | MP0003252_abnormal_bile_duct | 2.60245628 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.31126843 |
| 10 | MP0003303_peritoneal_inflammation | 2.25491997 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.16114725 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.15783300 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.02302787 |
| 14 | MP0005332_abnormal_amino_acid | 1.95551166 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 1.88538374 |
| 16 | MP0005083_abnormal_biliary_tract | 1.68611516 |
| 17 | MP0000609_abnormal_liver_physiology | 1.65353860 |
| 18 | MP0008057_abnormal_DNA_replication | 1.63191663 |
| 19 | MP0003186_abnormal_redox_activity | 1.61621293 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.61209778 |
| 21 | MP0003693_abnormal_embryo_hatching | 1.55687398 |
| 22 | MP0004381_abnormal_hair_follicle | 1.55137968 |
| 23 | MP0001764_abnormal_homeostasis | 1.54695772 |
| 24 | MP0005310_abnormal_salivary_gland | 1.52786570 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.51452104 |
| 26 | MP0003195_calcinosis | 1.50845712 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.49217628 |
| 28 | MP0008260_abnormal_autophagy | 1.48577725 |
| 29 | MP0000703_abnormal_thymus_morphology | 1.47258874 |
| 30 | MP0004947_skin_inflammation | 1.42576673 |
| 31 | MP0003436_decreased_susceptibility_to | 1.42273937 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.42000005 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.39875149 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.38653166 |
| 35 | MP0000490_abnormal_crypts_of | 1.31334737 |
| 36 | MP0010094_abnormal_chromosome_stability | 1.29666058 |
| 37 | MP0009697_abnormal_copulation | 1.26066441 |
| 38 | MP0000685_abnormal_immune_system | 1.24903307 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.22667049 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.22355875 |
| 41 | MP0003111_abnormal_nucleus_morphology | 1.21696463 |
| 42 | MP0009785_altered_susceptibility_to | 1.21381241 |
| 43 | MP0000598_abnormal_liver_morphology | 1.19720744 |
| 44 | MP0005075_abnormal_melanosome_morpholog | 1.19207074 |
| 45 | MP0008469_abnormal_protein_level | 1.17263227 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.15506422 |
| 47 | MP0002132_abnormal_respiratory_system | 1.14998161 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.14193862 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.13988110 |
| 50 | MP0005451_abnormal_body_composition | 1.13677069 |
| 51 | MP0005025_abnormal_response_to | 1.12777790 |
| 52 | MP0003724_increased_susceptibility_to | 1.11399823 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.10781248 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.10518279 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.10518279 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.09121853 |
| 57 | MP0004957_abnormal_blastocyst_morpholog | 1.09117690 |
| 58 | MP0003868_abnormal_feces_composition | 1.06226507 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.06150391 |
| 60 | MP0000678_abnormal_parathyroid_gland | 1.06140830 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.05464983 |
| 62 | MP0001800_abnormal_humoral_immune | 1.04260018 |
| 63 | MP0009278_abnormal_bone_marrow | 1.03659401 |
| 64 | MP0001873_stomach_inflammation | 1.03075494 |
| 65 | MP0003866_abnormal_defecation | 1.02379454 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 1.01965616 |
| 67 | MP0003077_abnormal_cell_cycle | 1.00988481 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.00706515 |
| 69 | MP0001663_abnormal_digestive_system | 1.00346139 |
| 70 | MP0009764_decreased_sensitivity_to | 0.99255160 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98533233 |
| 72 | MP0008058_abnormal_DNA_repair | 0.98321289 |
| 73 | MP0002419_abnormal_innate_immunity | 0.97951978 |
| 74 | MP0009763_increased_sensitivity_to | 0.97167940 |
| 75 | MP0001853_heart_inflammation | 0.96965900 |
| 76 | MP0000858_altered_metastatic_potential | 0.96046174 |
| 77 | MP0005174_abnormal_tail_pigmentation | 0.94700204 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 0.94662147 |
| 79 | MP0000689_abnormal_spleen_morphology | 0.94581457 |
| 80 | MP0005670_abnormal_white_adipose | 0.94195867 |
| 81 | MP0002163_abnormal_gland_morphology | 0.94086986 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.91522354 |
| 83 | MP0000372_irregular_coat_pigmentation | 0.91418093 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 0.90321919 |
| 85 | MP0002452_abnormal_antigen_presenting | 0.88248749 |
| 86 | MP0003718_maternal_effect | 0.88153466 |
| 87 | MP0001845_abnormal_inflammatory_respons | 0.87793766 |
| 88 | MP0001849_ear_inflammation | 0.85383848 |
| 89 | MP0002166_altered_tumor_susceptibility | 0.84629938 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 0.84277900 |
| 91 | MP0003075_altered_response_to | 0.83159824 |
| 92 | MP0002722_abnormal_immune_system | 0.83097703 |
| 93 | MP0001790_abnormal_immune_system | 0.82614257 |
| 94 | MP0005387_immune_system_phenotype | 0.82614257 |
| 95 | MP0002723_abnormal_immune_serum | 0.82584667 |
| 96 | MP0006082_CNS_inflammation | 0.82250025 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.81660101 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.79680906 |
| 99 | MP0002254_reproductive_system_inflammat | 0.79617053 |
| 100 | MP0002398_abnormal_bone_marrow | 0.79120740 |
| 101 | MP0003011_delayed_dark_adaptation | 0.78289446 |
| 102 | MP0006036_abnormal_mitochondrial_physio | 0.78008989 |
| 103 | MP0010307_abnormal_tumor_latency | 0.77561724 |
| 104 | MP0002429_abnormal_blood_cell | 0.77526613 |
| 105 | MP0005076_abnormal_cell_differentiation | 0.76885098 |
| 106 | MP0005647_abnormal_sex_gland | 0.76528294 |
| 107 | MP0005377_hearing/vestibular/ear_phenot | 0.76371750 |
| 108 | MP0003878_abnormal_ear_physiology | 0.76371750 |
| 109 | MP0002405_respiratory_system_inflammati | 0.75727139 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.75098397 |
| 111 | MP0003763_abnormal_thymus_physiology | 0.75008883 |
| 112 | MP0000716_abnormal_immune_system | 0.74526420 |
| 113 | MP0002970_abnormal_white_adipose | 0.74401354 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.74000967 |
| 115 | MP0001819_abnormal_immune_cell | 0.73799098 |
| 116 | MP0002420_abnormal_adaptive_immunity | 0.72959164 |
| 117 | MP0005000_abnormal_immune_tolerance | 0.71801537 |
| 118 | MP0000371_diluted_coat_color | 0.71167055 |
| 119 | MP0000313_abnormal_cell_death | 0.71012526 |
| 120 | MP0000477_abnormal_intestine_morphology | 0.70067746 |
| 121 | MP0005636_abnormal_mineral_homeostasis | 0.69981234 |
| 122 | MP0002148_abnormal_hypersensitivity_rea | 0.69700154 |
| 123 | MP0005376_homeostasis/metabolism_phenot | 0.69468060 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.69266607 |
| 125 | MP0005390_skeleton_phenotype | 0.68741012 |
| 126 | MP0004510_myositis | 0.68434740 |
| 127 | MP0005381_digestive/alimentary_phenotyp | 0.68124817 |
| 128 | MP0009642_abnormal_blood_homeostasis | 0.67819590 |
| 129 | MP0000465_gastrointestinal_hemorrhage | 0.67263589 |
| 130 | MP0002060_abnormal_skin_morphology | 0.67033770 |
| 131 | MP0003786_premature_aging | 0.67000532 |
| 132 | MP0000681_abnormal_thyroid_gland | 0.66742793 |
| 133 | MP0002693_abnormal_pancreas_physiology | 0.66688095 |
| 134 | MP0005266_abnormal_metabolism | 0.66626112 |
| 135 | MP0005379_endocrine/exocrine_gland_phen | 0.66526034 |
| 136 | MP0009931_abnormal_skin_appearance | 0.65610457 |
| 137 | MP0005671_abnormal_response_to | 0.64386975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.02954281 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.91360369 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.89223080 |
| 4 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.84391201 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.58658200 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.46070078 |
| 7 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.43300381 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.41122452 |
| 9 | Xanthomatosis (HP:0000991) | 4.14086227 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.12025003 |
| 11 | Deep venous thrombosis (HP:0002625) | 4.04866250 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.79035686 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.78676614 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.74632030 |
| 15 | Joint hemorrhage (HP:0005261) | 3.67782711 |
| 16 | Panhypogammaglobulinemia (HP:0003139) | 3.64905546 |
| 17 | Hyperammonemia (HP:0001987) | 3.57811529 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.57380120 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.57324164 |
| 20 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.50007832 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.43645033 |
| 22 | Recurrent skin infections (HP:0001581) | 3.42748323 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.42128377 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.42128377 |
| 25 | Hyperglycinuria (HP:0003108) | 3.38244650 |
| 26 | Abnormality of macrophages (HP:0004311) | 3.37966940 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.34190855 |
| 28 | Obstructive lung disease (HP:0006536) | 3.34190855 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 3.30402044 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.29288744 |
| 31 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.23663425 |
| 32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.23663425 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 3.23663425 |
| 34 | Hyperlipoproteinemia (HP:0010980) | 3.23149546 |
| 35 | Hypolipoproteinemia (HP:0010981) | 3.21404042 |
| 36 | Recurrent viral infections (HP:0004429) | 3.20349153 |
| 37 | Abnormality of methionine metabolism (HP:0010901) | 3.19088289 |
| 38 | Complement deficiency (HP:0004431) | 3.17048307 |
| 39 | Colitis (HP:0002583) | 3.07747097 |
| 40 | Agammaglobulinemia (HP:0004432) | 3.06497615 |
| 41 | Myositis (HP:0100614) | 3.05537962 |
| 42 | Gastrointestinal inflammation (HP:0004386) | 3.05373417 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 3.03564951 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.03564951 |
| 45 | Meningitis (HP:0001287) | 3.03410166 |
| 46 | Hyperglycinemia (HP:0002154) | 3.01910795 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.96107186 |
| 48 | Stomatitis (HP:0010280) | 2.95768107 |
| 49 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.95181537 |
| 50 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.89013880 |
| 51 | Abnormality of complement system (HP:0005339) | 2.88390410 |
| 52 | Abnormality of nucleobase metabolism (HP:0010932) | 2.86784708 |
| 53 | Fat malabsorption (HP:0002630) | 2.84472062 |
| 54 | Ketosis (HP:0001946) | 2.78138464 |
| 55 | Hypoglycemic coma (HP:0001325) | 2.73709789 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.69748375 |
| 57 | Epidermoid cyst (HP:0200040) | 2.62826313 |
| 58 | Hypoalphalipoproteinemia (HP:0003233) | 2.61400426 |
| 59 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.61113463 |
| 60 | Abnormality of the common coagulation pathway (HP:0010990) | 2.56754360 |
| 61 | Reticulocytopenia (HP:0001896) | 2.56752933 |
| 62 | Pustule (HP:0200039) | 2.56575076 |
| 63 | Encephalitis (HP:0002383) | 2.55214857 |
| 64 | Myocardial infarction (HP:0001658) | 2.54428613 |
| 65 | Dicarboxylic aciduria (HP:0003215) | 2.53783842 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53783842 |
| 67 | Gingival bleeding (HP:0000225) | 2.53191682 |
| 68 | Abnormality of T cells (HP:0002843) | 2.50985776 |
| 69 | Hyperbilirubinemia (HP:0002904) | 2.47918411 |
| 70 | Hypercholesterolemia (HP:0003124) | 2.47521711 |
| 71 | Severe visual impairment (HP:0001141) | 2.45160070 |
| 72 | Abnormality of serum amino acid levels (HP:0003112) | 2.44849109 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43453823 |
| 74 | Increased IgE level (HP:0003212) | 2.36841046 |
| 75 | Abnormality of the intrinsic pathway (HP:0010989) | 2.34404039 |
| 76 | Loss of speech (HP:0002371) | 2.34344761 |
| 77 | Orchitis (HP:0100796) | 2.33337216 |
| 78 | Delayed CNS myelination (HP:0002188) | 2.32926983 |
| 79 | Systemic lupus erythematosus (HP:0002725) | 2.32558710 |
| 80 | Cellulitis (HP:0100658) | 2.32151926 |
| 81 | Conjugated hyperbilirubinemia (HP:0002908) | 2.31297792 |
| 82 | Hypertensive crisis (HP:0100735) | 2.31265941 |
| 83 | Reduced antithrombin III activity (HP:0001976) | 2.29823975 |
| 84 | Hypochromic microcytic anemia (HP:0004840) | 2.29195376 |
| 85 | Generalized aminoaciduria (HP:0002909) | 2.28520771 |
| 86 | Renal cortical cysts (HP:0000803) | 2.27500996 |
| 87 | Vasculitis (HP:0002633) | 2.26156648 |
| 88 | J-shaped sella turcica (HP:0002680) | 2.25100671 |
| 89 | Stridor (HP:0010307) | 2.22012521 |
| 90 | Lymphopenia (HP:0001888) | 2.21968116 |
| 91 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.21931992 |
| 92 | Hypochromic anemia (HP:0001931) | 2.18865299 |
| 93 | Steatorrhea (HP:0002570) | 2.18443569 |
| 94 | Viral hepatitis (HP:0006562) | 2.18314548 |
| 95 | Metabolic acidosis (HP:0001942) | 2.18187590 |
| 96 | Spastic diplegia (HP:0001264) | 2.17285789 |
| 97 | Malnutrition (HP:0004395) | 2.16664366 |
| 98 | Hepatocellular carcinoma (HP:0001402) | 2.16295025 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 2.15899461 |
| 100 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.14809829 |
| 101 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14512404 |
| 102 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14512404 |
| 103 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14512404 |
| 104 | Nausea (HP:0002018) | 2.14038686 |
| 105 | Gastrointestinal stroma tumor (HP:0100723) | 2.11339929 |
| 106 | Thoracic kyphosis (HP:0002942) | 2.09626622 |
| 107 | Abnormality of purine metabolism (HP:0004352) | 2.08526872 |
| 108 | Menorrhagia (HP:0000132) | 2.08395461 |
| 109 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.08211659 |
| 110 | Gastrointestinal infarctions (HP:0005244) | 2.07919388 |
| 111 | Epistaxis (HP:0000421) | 2.07839916 |
| 112 | Albinism (HP:0001022) | 2.05117271 |
| 113 | Lethargy (HP:0001254) | 2.04990457 |
| 114 | Microretrognathia (HP:0000308) | 2.04286706 |
| 115 | Hepatosplenomegaly (HP:0001433) | 2.03018684 |
| 116 | Thrombocytosis (HP:0001894) | 2.02060027 |
| 117 | Increased serum ferritin (HP:0003281) | 2.01694649 |
| 118 | Prostate neoplasm (HP:0100787) | 2.01653925 |
| 119 | Chest pain (HP:0100749) | 2.01281425 |
| 120 | Osteomyelitis (HP:0002754) | 2.01238527 |
| 121 | Urticaria (HP:0001025) | 2.01104185 |
| 122 | Abnormal platelet volume (HP:0011876) | 1.99541210 |
| 123 | Seborrheic dermatitis (HP:0001051) | 1.98976758 |
| 124 | Opisthotonus (HP:0002179) | 1.97461470 |
| 125 | Polygenic inheritance (HP:0010982) | 1.97179022 |
| 126 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.95475919 |
| 127 | Vascular calcification (HP:0004934) | 1.95408826 |
| 128 | Microcytic anemia (HP:0001935) | 1.95246354 |
| 129 | Purpura (HP:0000979) | 1.94574138 |
| 130 | Glomerulonephritis (HP:0000099) | 1.93666844 |
| 131 | Spontaneous hematomas (HP:0007420) | 1.93606188 |
| 132 | Retrobulbar optic neuritis (HP:0100654) | 1.92097389 |
| 133 | Optic neuritis (HP:0100653) | 1.92097389 |
| 134 | Increased IgM level (HP:0003496) | 1.90447226 |
| 135 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.90247791 |
| 136 | Oral leukoplakia (HP:0002745) | 1.89777875 |
| 137 | Impaired platelet aggregation (HP:0003540) | 1.89386638 |
| 138 | Abnormal platelet function (HP:0011869) | 1.89386638 |
| 139 | Abnormal number of erythroid precursors (HP:0012131) | 1.89213323 |
| 140 | Abnormality of the prostate (HP:0008775) | 1.89169198 |
| 141 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.88653170 |
| 142 | Villous atrophy (HP:0011473) | 1.88653170 |
| 143 | Hemoptysis (HP:0002105) | 1.88387185 |
| 144 | Prolonged bleeding time (HP:0003010) | 1.88205215 |
| 145 | Pulmonary infiltrates (HP:0002113) | 1.86011791 |
| 146 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.84701770 |
| 147 | Abnormality of T cell physiology (HP:0011840) | 1.84135557 |
| 148 | Acanthocytosis (HP:0001927) | 1.83987007 |
| 149 | Mucopolysacchariduria (HP:0008155) | 1.83576140 |
| 150 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83576140 |
| 151 | Proximal tubulopathy (HP:0000114) | 1.83367709 |
| 152 | Pancreatitis (HP:0001733) | 1.82703913 |
| 153 | Increased mean platelet volume (HP:0011877) | 1.82321809 |
| 154 | Thrombophlebitis (HP:0004418) | 1.82086053 |
| 155 | Cerebral palsy (HP:0100021) | 1.79549230 |
| 156 | Esophageal varix (HP:0002040) | 1.78882080 |
| 157 | Petechiae (HP:0000967) | 1.78577751 |
| 158 | Recurrent lower respiratory tract infections (HP:0002783) | 1.78191311 |
| 159 | Abnormality of reticulocytes (HP:0004312) | 1.77942627 |
| 160 | Abnormality of the thoracic spine (HP:0100711) | 1.77866106 |
| 161 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.77426272 |
| 162 | Poikiloderma (HP:0001029) | 1.77231046 |
| 163 | Vacuolated lymphocytes (HP:0001922) | 1.76681764 |
| 164 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76212890 |
| 165 | Elevated hepatic transaminases (HP:0002910) | 1.74981619 |
| 166 | Gingivitis (HP:0000230) | 1.74956391 |
| 167 | Chromsome breakage (HP:0040012) | 1.74367899 |
| 168 | Hypertriglyceridemia (HP:0002155) | 1.74206682 |
| 169 | Poikilocytosis (HP:0004447) | 1.72807249 |
| 170 | Ketoacidosis (HP:0001993) | 1.72763858 |
| 171 | Gastrointestinal dysmotility (HP:0002579) | 1.69473071 |
| 172 | Prolonged neonatal jaundice (HP:0006579) | 1.68771142 |
| 173 | Hydroxyprolinuria (HP:0003080) | 1.68676675 |
| 174 | Abnormality of proline metabolism (HP:0010907) | 1.68676675 |
| 175 | Cheilitis (HP:0100825) | 1.68591446 |
| 176 | Recurrent bacterial skin infections (HP:0005406) | 1.68338550 |
| 177 | Verrucae (HP:0200043) | 1.67879687 |
| 178 | Papilloma (HP:0012740) | 1.67879687 |
| 179 | Cardiovascular calcification (HP:0011915) | 1.64585042 |
| 180 | Autoimmune thrombocytopenia (HP:0001973) | 1.63735270 |
| 181 | Abnormal cartilage morphology (HP:0002763) | 1.62577423 |
| 182 | Vomiting (HP:0002013) | 1.62199563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SMG1 | 4.12640783 |
| 2 | BCKDK | 3.49459463 |
| 3 | VRK2 | 2.97674585 |
| 4 | ERN1 | 2.75429862 |
| 5 | MAP4K1 | 2.28010644 |
| 6 | MAP3K10 | 2.19561674 |
| 7 | FLT3 | 2.15189405 |
| 8 | TNK2 | 2.12965382 |
| 9 | FGFR4 | 2.03132807 |
| 10 | NME2 | 1.91113595 |
| 11 | STK16 | 1.73139064 |
| 12 | NEK2 | 1.71303334 |
| 13 | WEE1 | 1.70531261 |
| 14 | BLK | 1.70458949 |
| 15 | PRPF4B | 1.70120272 |
| 16 | TYK2 | 1.69965923 |
| 17 | MAP2K3 | 1.69375081 |
| 18 | RIPK4 | 1.68586424 |
| 19 | IRAK3 | 1.68568044 |
| 20 | KIT | 1.62708996 |
| 21 | TLK1 | 1.58247874 |
| 22 | FES | 1.55523507 |
| 23 | CDK7 | 1.52185744 |
| 24 | MAPK11 | 1.51903505 |
| 25 | ACVR1B | 1.51187764 |
| 26 | TAF1 | 1.50098674 |
| 27 | MAP3K11 | 1.44277729 |
| 28 | TBK1 | 1.43275496 |
| 29 | BUB1 | 1.40515146 |
| 30 | MST1R | 1.37905985 |
| 31 | TXK | 1.36376467 |
| 32 | EEF2K | 1.34386177 |
| 33 | PKN2 | 1.32465024 |
| 34 | CSF1R | 1.31366313 |
| 35 | IRAK4 | 1.30103105 |
| 36 | DYRK3 | 1.30065828 |
| 37 | MATK | 1.29827883 |
| 38 | TEC | 1.29489922 |
| 39 | EIF2AK1 | 1.29466862 |
| 40 | BTK | 1.29341854 |
| 41 | GRK6 | 1.28713230 |
| 42 | CSK | 1.28483277 |
| 43 | KDR | 1.28411586 |
| 44 | CDK4 | 1.27212691 |
| 45 | MAP3K14 | 1.26483763 |
| 46 | PIM1 | 1.26322088 |
| 47 | TAOK3 | 1.20869787 |
| 48 | SIK1 | 1.20339856 |
| 49 | PIM2 | 1.20248676 |
| 50 | RPS6KB2 | 1.16746416 |
| 51 | IKBKB | 1.15477495 |
| 52 | PRKD2 | 1.14863485 |
| 53 | STK10 | 1.13455462 |
| 54 | CDC7 | 1.10655790 |
| 55 | TAOK1 | 1.08308200 |
| 56 | TTK | 1.07491112 |
| 57 | HIPK2 | 1.04692073 |
| 58 | TGFBR1 | 1.03468104 |
| 59 | STK4 | 1.01242058 |
| 60 | RPS6KA4 | 1.00747802 |
| 61 | EPHA2 | 1.00721482 |
| 62 | ZAP70 | 0.99807006 |
| 63 | ATR | 0.98437288 |
| 64 | MAPK15 | 0.95856617 |
| 65 | MARK3 | 0.95854461 |
| 66 | IKBKE | 0.95548231 |
| 67 | TGFBR2 | 0.95063507 |
| 68 | CDK12 | 0.92774249 |
| 69 | ICK | 0.91640064 |
| 70 | NUAK1 | 0.90935225 |
| 71 | IRAK2 | 0.90517968 |
| 72 | JAK3 | 0.89292794 |
| 73 | MAPKAPK3 | 0.89278136 |
| 74 | AURKB | 0.88751920 |
| 75 | SIK3 | 0.88022156 |
| 76 | YES1 | 0.86233019 |
| 77 | CDK6 | 0.86123196 |
| 78 | ZAK | 0.86122009 |
| 79 | MAP3K6 | 0.84722249 |
| 80 | MAP3K3 | 0.84317915 |
| 81 | PLK1 | 0.83444408 |
| 82 | MAP3K8 | 0.82854034 |
| 83 | LYN | 0.80968597 |
| 84 | PTK6 | 0.78338780 |
| 85 | ADRBK2 | 0.77312615 |
| 86 | CDC42BPA | 0.77010212 |
| 87 | IRAK1 | 0.76479643 |
| 88 | ITK | 0.76024697 |
| 89 | DYRK1B | 0.74931712 |
| 90 | PAK4 | 0.73748019 |
| 91 | MAP2K2 | 0.72089387 |
| 92 | TIE1 | 0.71982305 |
| 93 | HCK | 0.71204258 |
| 94 | BMX | 0.71134352 |
| 95 | BRSK2 | 0.70794004 |
| 96 | TRIB3 | 0.67718249 |
| 97 | MAP2K6 | 0.67659912 |
| 98 | ABL2 | 0.66563121 |
| 99 | TESK2 | 0.64518341 |
| 100 | CHUK | 0.63965436 |
| 101 | DAPK1 | 0.63307344 |
| 102 | MAP3K1 | 0.62736103 |
| 103 | SRPK1 | 0.61293594 |
| 104 | NEK9 | 0.60745248 |
| 105 | PRKCI | 0.60091698 |
| 106 | TAOK2 | 0.60035733 |
| 107 | EIF2AK3 | 0.59877354 |
| 108 | CHEK2 | 0.58843115 |
| 109 | JAK2 | 0.58085855 |
| 110 | PIK3CG | 0.53726171 |
| 111 | PRKAA2 | 0.52125413 |
| 112 | NME1 | 0.51821775 |
| 113 | FGR | 0.50563118 |
| 114 | LRRK2 | 0.50501476 |
| 115 | VRK1 | 0.50049072 |
| 116 | EIF2AK2 | 0.49923371 |
| 117 | RPS6KA6 | 0.49730619 |
| 118 | PRKG2 | 0.49444142 |
| 119 | MAPKAPK2 | 0.48145381 |
| 120 | LCK | 0.46818152 |
| 121 | STK38L | 0.46815006 |
| 122 | CDK9 | 0.46180455 |
| 123 | MAPK4 | 0.45965057 |
| 124 | RPS6KA2 | 0.45751622 |
| 125 | PDPK1 | 0.45587558 |
| 126 | RPS6KC1 | 0.45298320 |
| 127 | RPS6KL1 | 0.45298320 |
| 128 | PLK4 | 0.45039216 |
| 129 | AURKA | 0.44588689 |
| 130 | PRKD3 | 0.44033377 |
| 131 | CSNK2A1 | 0.43864132 |
| 132 | SYK | 0.43831655 |
| 133 | PRKCQ | 0.42972870 |
| 134 | DAPK3 | 0.39855618 |
| 135 | PDK1 | 0.39001982 |
| 136 | FRK | 0.37174161 |
| 137 | CAMK1D | 0.35506096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.10482481 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.94163509 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.58151755 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.53375666 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.40005773 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.24183756 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.22185823 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.20764363 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.17358690 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.10269400 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.06397817 |
| 12 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.06223532 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.00669139 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.99188057 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.95419875 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.91912420 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.91456484 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.89702190 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.83201723 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.82812958 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.82790257 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.82473660 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78938740 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.76245472 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76232491 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.75704057 |
| 27 | Mismatch repair_Homo sapiens_hsa03430 | 1.74728030 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.71675476 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.71478964 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.65605088 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61742892 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.59256065 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.58031124 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.57503953 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.56701298 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.55979138 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.54832269 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.54384968 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.52918872 |
| 40 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.48294885 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46243613 |
| 42 | Base excision repair_Homo sapiens_hsa03410 | 1.45016205 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.45014513 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.44686879 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39647470 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39520514 |
| 47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39346676 |
| 48 | Ribosome_Homo sapiens_hsa03010 | 1.37835556 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.37409817 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36303769 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36286717 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.35886450 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.33013232 |
| 54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.30693631 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25428804 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25018675 |
| 57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.22368070 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21039727 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20499439 |
| 60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16787726 |
| 61 | Homologous recombination_Homo sapiens_hsa03440 | 1.11935952 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.09244438 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08855894 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08487140 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07752663 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07402680 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06557745 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06545257 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06451474 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 1.06427045 |
| 71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.05151889 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04062961 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 1.02906596 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98282350 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.96910717 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95707617 |
| 77 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.94588734 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94503990 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.93887981 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91672063 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89710857 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89062461 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88720018 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.86652129 |
| 85 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86466157 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85502484 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.84063924 |
| 88 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.84030181 |
| 89 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.84004401 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83911052 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.82189449 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81546776 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78636267 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77822785 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76801283 |
| 96 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75381599 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75108418 |
| 98 | Bile secretion_Homo sapiens_hsa04976 | 0.74541030 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74493854 |
| 100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72464543 |
| 101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72401294 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72207260 |
| 103 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71923757 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.69447407 |
| 105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69295438 |
| 106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69035421 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.68654086 |
| 108 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.67320748 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.66999179 |
| 110 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.66912425 |
| 111 | Pertussis_Homo sapiens_hsa05133 | 0.62524749 |
| 112 | Spliceosome_Homo sapiens_hsa03040 | 0.61907405 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60045550 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57286835 |
| 115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57100034 |
| 116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56710510 |
| 117 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55842685 |
| 118 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55696479 |
| 119 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55376821 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52444600 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52165280 |
| 122 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51646091 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50108098 |
| 124 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49514991 |
| 125 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49511453 |
| 126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49382930 |
| 127 | Malaria_Homo sapiens_hsa05144 | 0.49204798 |
| 128 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49187258 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49081494 |
| 130 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48514549 |
| 131 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47415993 |
| 132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46264066 |
| 133 | Proteasome_Homo sapiens_hsa03050 | 0.45596838 |
| 134 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.45490276 |
| 135 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45377230 |
| 136 | Legionellosis_Homo sapiens_hsa05134 | 0.43663363 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.43318453 |
| 138 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43119871 |
| 139 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42981181 |
| 140 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.42687322 |
| 141 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41604722 |
| 142 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40659929 |
| 143 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40079359 |
| 144 | Cell cycle_Homo sapiens_hsa04110 | 0.40036601 |
| 145 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39965147 |
| 146 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38804456 |
| 147 | RNA transport_Homo sapiens_hsa03013 | 0.38517618 |
| 148 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.37637074 |
| 149 | Platelet activation_Homo sapiens_hsa04611 | 0.36952578 |
| 150 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36948088 |
| 151 | Insulin resistance_Homo sapiens_hsa04931 | 0.36225106 |
| 152 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35833642 |
| 153 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.35790753 |
| 154 | RNA polymerase_Homo sapiens_hsa03020 | 0.34695155 |
| 155 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34417509 |
| 156 | Measles_Homo sapiens_hsa05162 | 0.26368826 |
| 157 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25492889 |
| 158 | Leishmaniasis_Homo sapiens_hsa05140 | 0.24249977 |
| 159 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.23907074 |
| 160 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21373223 |

